99 related articles for article (PubMed ID: 4546887)
1. Primary and secondary immune response induced in vitro against syngeneic murine plasma cell tumors.
Röllinghoff M; Wagner H
Boll Ist Sieroter Milan; 1974; 53(1):suppl:304. PubMed ID: 4546887
[No Abstract] [Full Text] [Related]
2. In vitro induction of tumor specific immunity: requirements for T lymphocytes and tumor growth inhibition in vivo.
Röllinghoff M; Wagner H
Eur J Immunol; 1973 Aug; 3(8):471-6. PubMed ID: 4543174
[No Abstract] [Full Text] [Related]
3. Secondary cytotoxic tumor immune response induced in vitro.
Röllinghoff M
J Immunol; 1974 May; 112(5):1718-25. PubMed ID: 4544796
[No Abstract] [Full Text] [Related]
4. Tumor immunity to murine plasma cell tumors. II. Essential role of T lymphocytes in immune response.
Rouse BT; Röllinghoff M; Warner NL
Eur J Immunol; 1973 Apr; 3(4):218-24. PubMed ID: 4541468
[No Abstract] [Full Text] [Related]
5. In vivo activity of in vitro immunized lymphocytes. I. Tumor allograft rejection mediated by in vitro activated mouse thymocytes.
Rouse BT; Wagner H; Harris AW
J Immunol; 1972 May; 108(5):1353-61. PubMed ID: 4623947
[No Abstract] [Full Text] [Related]
6. Regulation of the immune response by subclasses of T lymphocytes. II. The effect of adult thymectomy upon humoral and cellular responses in mice.
Simpson E; Cantor H
Eur J Immunol; 1975 May; 5(5):337-43. PubMed ID: 1086235
[TBL] [Abstract][Full Text] [Related]
7. Heterologous antiserum to mouse thymus-derived lymphocytes.
Bron C; Sauser D
J Immunol; 1973 Feb; 110(2):384-9. PubMed ID: 4567392
[No Abstract] [Full Text] [Related]
8. The role of humoral factors in the initiation of in vitro primary immune responses. IV. Are macrophages the adherent cell type required for cell cooperation.
Watson J; Thoman M; Ralph P; Trenkner E
J Immunol; 1974 May; 112(5):1873-83. PubMed ID: 4131877
[No Abstract] [Full Text] [Related]
9. Comparative in vitro studies on effector cell diversity in the cellular immune response to murine sarcoma virus (MSV)-induced tumors in mice.
Plata F; Gomard E; Leclerc JC; Levy JP
J Immunol; 1974 Apr; 112(4):1477-87. PubMed ID: 4360862
[No Abstract] [Full Text] [Related]
10. Effect of azathioprine and cytosine arabinoside on humoral and cellular immunity in vitro.
Röllinghoff M; Schrader J; Wagner H
Clin Exp Immunol; 1973 Oct; 15(2):261-9. PubMed ID: 4543428
[TBL] [Abstract][Full Text] [Related]
11. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. I. Analysis of immune parameters involved.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):133-43. PubMed ID: 6265346
[TBL] [Abstract][Full Text] [Related]
12. Cellular specificity of plasmacytoma-induced immunosuppression.
Zolla-Pazner S; Sullivan B; Richardson D
J Immunol; 1976 Aug; 117(2):563-8. PubMed ID: 1084903
[TBL] [Abstract][Full Text] [Related]
13. Regulation of immune responses against the syngeneic ADJ-PC-5 plasmacytoma in BALB/c mice. II. Suppression of T-cell cytotoxicity by pretreatment of mice with subimmunogenic doses of tumour cells.
Cihak J; Ziegler HW; Kölsch E
Immunology; 1981 May; 43(1):145-52. PubMed ID: 6972902
[TBL] [Abstract][Full Text] [Related]
14. Lymphoid cell dependence of eosinophil response to antigen. 3. Comparison of the rate of appearance of two types of memory cells in various lymphoid tissues at different times after priming.
Ponzio NM; Speirs RS
J Immunol; 1973 May; 110(5):1363-70. PubMed ID: 4735383
[No Abstract] [Full Text] [Related]
15. Tumor immunity to murine plasma cell tumors. V. Genetic control of the in vitro cytotoxic T-cell response to plasma cell tumor-associated antigens of NZB mice.
Burton RC; Warner NL
J Natl Cancer Inst; 1980 Aug; 65(2):431-40. PubMed ID: 6967529
[TBL] [Abstract][Full Text] [Related]
16. Cellular immunoadsorbents: a simplified technique for separation of lymphoid cell populations.
Kedar E; Ortiz de Landazuri M; Bonavida B
J Immunol; 1974 Mar; 112(3):1231-43. PubMed ID: 4590702
[No Abstract] [Full Text] [Related]
17. Relation of DNA synthesis and suppression to development of memory by T cells.
Mills VA; Orbach-Arbouys S; Gershon RK
J Immunol; 1975 Jan; 114(1 Pt 1):200-5. PubMed ID: 1078676
[TBL] [Abstract][Full Text] [Related]
18. The role of tumor-specific Lyt-1+2- T cells in eradicating tumor cells in vivo. I. Lyt-1+2- T cells do not necessarily require recruitment of host's cytotoxic T cell precursors for implementation of in vivo immunity.
Fujiwara H; Fukuzawa M; Yoshioka T; Nakajima H; Hamaoka T
J Immunol; 1984 Sep; 133(3):1671-6. PubMed ID: 6205091
[TBL] [Abstract][Full Text] [Related]
19. Phagocytic cells as effectors in a cell-mediated immunity system.
Dennert G; Lennox ES
J Immunol; 1973 Dec; 111(6):1844-54. PubMed ID: 4543031
[No Abstract] [Full Text] [Related]
20. Brief communication: In vivo protection against murine plasma cell tumor growth by in vitro activated syngeneic lymphocytes.
Röllinghoff M; Wagner H
J Natl Cancer Inst; 1973 Oct; 51(4):1317-8. PubMed ID: 4745860
[No Abstract] [Full Text] [Related]
[Next] [New Search]
